Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ATOS
CNTX
Add up to 3 more stocks
ATOS
Atossa Therapeutics, Inc.
+0.61%
$2.46+0.01Delayed quote: Oct 6, 2026, 10:41 AM EDT
Market Cap
$24.59M
52W Range
$1.70 - $19.35
CNTX
Context Therapeutics Inc.
-0.92%
$0.33-0.00Delayed quote: Oct 6, 2026, 10:44 AM EDT
Market Cap
$30.63M
52W Range
$0.30 - $3.62
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.92 | 0.80 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -140.6% | -120.4% |
| ROA | -116.8% | -99.6% |
| ROIC | -146.3% | -126.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.69 | 5.81 |
| Quick Ratio | 5.69 | 5.81 |
| Debt/Equity | 0.00 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.